Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dermal Hypersensitivity Reaction”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00274352
What this trial is testing

Adalimumab to Treat Sarcoidosis of the Skin

Who this might be right for
Sarcoidosis
Pariser, Robert J., M.D. 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05458492
What this trial is testing

Sirolimus in Cutaneous Sarcoidosis

Who this might be right for
SarcoidosisCutaneous Sarcoidosis
Assistance Publique - Hôpitaux de Paris 10
Not applicableStudy completedNCT06522048
What this trial is testing

SJS/TEN or Other Cutaneous Adverse Eevents Induced by Immune Checkpoint Inhibitors (ICIs) vs. Non-ICIs

Who this might be right for
Immune Checkpoint Inhibitor-Induced DermatitisStevens-Johnson Syndrome, Drug-InducedToxic Epidermal Necrolysis Due to Drug
Chao Ji 300
Not applicableStudy completedNCT05094687
What this trial is testing

Cutaneous Manifestations of Coronavirus Disease 2019(COVID-19).

Who this might be right for
Cutaneous ManifestationsSkin ManifestationsCOVID-19+5 more
Jinnah Postgraduate Medical Centre 1,206
Testing effectiveness (Phase 2)Study completedNCT01037881
What this trial is testing

LEO 29102 Cream in the Treatment of Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
LEO Pharma 183
Post-approval studies (Phase 4)Ended earlyNCT03389893
What this trial is testing

Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
National Institute of Allergy and Infectious Diseases (NIAID) 72
Large-scale testing (Phase 3)Study completedNCT01105507
What this trial is testing

The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada

Who this might be right for
Cryopyrin Associated Periodic Syndrome
Novartis Pharmaceuticals 4
Not applicableStudy completedNCT00461721
What this trial is testing

Pilot Trial to Elaborate a Cutaneous Antigen Neutralization Test in Patients Suffering From Rhinoconjunctivitis

Who this might be right for
Allergy
University of Zurich 20
Large-scale testing (Phase 3)Study completedNCT00794274
What this trial is testing

The Efficacy and Safety of CC-10004 in Chronic Cutaneous Sarcoidosis

Who this might be right for
SarcoidosisCutaneous Sarcoidosis
University of Cincinnati 15
Not applicableLooking for participantsNCT06599411
What this trial is testing

Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases

Who this might be right for
Atopic DermatitisPsoriasisHidradenitis Suppurativa+9 more
Assistance Publique - Hôpitaux de Paris 830
Large-scale testing (Phase 3)UnknownNCT02348905
What this trial is testing

ACTHAR Gel for Cutaneous Sarcoidosis: An Open Label Trial

Who this might be right for
SarcoidosisCutaneous Sarcoidosis
Albany Medical College 10
Large-scale testing (Phase 3)Study completedNCT00413556
What this trial is testing

Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets

Who this might be right for
Allergy
ALK-Abelló A/S 76
Not applicableStudy completedNCT06551363
What this trial is testing

Atopic Dermatitis Cutaneous Discomfort of the Infant Under the Age of One Year : Analysis of Filmed Sequences (PRE-PRURINEO)

Who this might be right for
Atopic Dermatitis
University Hospital, Brest 7
Testing effectiveness (Phase 2)WithdrawnNCT06725264
What this trial is testing

Tyrosine Kinase 2 (TYK2) for GA and CS

Who this might be right for
SarcoidosisGranuloma Annulare
Yale University
Not applicableLooking for participantsNCT03004326
What this trial is testing

Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

Who this might be right for
Cryoglobulinemic Vasculitis (CV)Drug-induced VasculitisEosinophilic Granulomatosis With Polyangiitis (EGPA)+7 more
Peter Merkel 50
Testing effectiveness (Phase 2)WithdrawnNCT00731757
What this trial is testing

Efficacy Study of Humira in the Treatment of Cutaneous Sarcoidosis

Who this might be right for
SarcoidosisCutaneous Sarcoidosis
Wright State University
Large-scale testing (Phase 3)Study completedNCT01916980
What this trial is testing

Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Eczema/Dermatitis and Dermal Pruritus (MK-4117-202)

Who this might be right for
EczemaDermatitisDermal Pruritus
Organon and Co 94
Not applicableLooking for participantsNCT07444008
What this trial is testing

Randomized, Blinded, Placebo-Controlled Evaluation of BioAmicus Complete

Who this might be right for
Infantile ColicsConstipationInfantile Diarrhea+1 more
NovoNatum Ltd 140
Testing effectiveness (Phase 2)Study completedNCT02005627
What this trial is testing

Grass Pollen Allergen Immunotherapy Tablet (AIT) Time Course Study

Who this might be right for
Allergic Rhinitis
Imperial College London 46
Not applicableStudy completedNCT01086319
What this trial is testing

Risk of Hospitalization for Severe Hypersensitivity (Including Severe Skin Reactions) in Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatments

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 113,505
Next Page